רספרים

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

SULPHAMETHOXAZOLE; TRIMETHOPRIM

Tersedia dari:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Kode ATC:

J01EE01

Bentuk farmasi:

תרחיף

Komposisi:

SULPHAMETHOXAZOLE 200 MG / 5 ML; TRIMETHOPRIM 40 MG / 5 ML

Rute administrasi :

פומי

Jenis Resep:

מרשם נדרש

Diproduksi oleh:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Kelompok Terapi:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Area terapi:

SULFAMETHOXAZOLE AND TRIMETHOPRIM

Indikasi Terapi:

Treatment of urinary tract infections due to susceptible strains of the following organisms: - Escherichia coli - Klebsiella - Enterobacter - Proteus mirabilis - Proteus vulgaris - Proteus morganii. Treatment of acute otitis media in children due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. To date there are limited data available as to the safety of repeated use of Resprim in infants under 2 years of age. Resprim is not indicated for prophylactic or prolonged administration in otitis media at any age. Treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Haemophilus influenzae or Streptococcus pneumoniae. Treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei. Resprim is also indicated in the treatment of documented Pneumocystis carinii pneumonitis.

Tanggal Otorisasi:

2012-01-31